SARS-CoV-2 vaccines - the biggest medical research project of the 21st century

Curr Opin Virol. 2021 Aug:49:52-57. doi: 10.1016/j.coviro.2021.04.008. Epub 2021 May 4.

Abstract

SARS-CoV-2 has been detected in more than 141 million people and caused more than 3 million deaths worldwide. To reduce the additional loss of millions of lives until natural immunity is reached, researchers have focused on the only known method to stop the COVID-19 pandemic: vaccines. The pandemic has propelled high-speed vaccine development, some based on novel technology previously not utilized in the vaccine field. The new technology opens new possibilities and comes with challenges because the long-term performance of the new platforms is unknown. Here we review the current leading vaccine candidates against COVID-19 and outline the advantages and disadvantages as well as the unknowns of each candidate.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenoviridae / genetics
  • Biomedical Research* / statistics & numerical data
  • Biomedical Research* / trends
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / adverse effects
  • COVID-19 Vaccines / genetics
  • COVID-19 Vaccines / immunology*
  • Humans
  • Mutation
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • Vaccines, Inactivated / administration & dosage
  • Vaccines, Inactivated / adverse effects
  • Vaccines, Inactivated / genetics
  • Vaccines, Inactivated / immunology
  • Vaccines, Subunit / administration & dosage
  • Vaccines, Subunit / adverse effects
  • Vaccines, Subunit / genetics
  • Vaccines, Subunit / immunology
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / adverse effects
  • Vaccines, Synthetic / genetics
  • Vaccines, Synthetic / immunology
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Inactivated
  • Vaccines, Subunit
  • Vaccines, Synthetic